This inventor holds 6 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Cenix Bioscience Gmbh, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Other. Active years: 2008-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 4 
2 out of 1,334 
1 out of 834,513 Years Active: 2008-2025
Title: The Innovative Contributions of Anthony A Hyman
Introduction
Anthony A Hyman is a prominent inventor based in Dresden, Germany. He has made significant contributions to the field of neurodegenerative disease research, holding a total of 6 patents. His work focuses on developing compounds that can potentially treat various neurodegenerative conditions.
Latest Patents
Hyman's latest patents include innovative compounds for the treatment of diseases and methods of screening for these compounds. One notable invention relates to a compound for use in the prevention or treatment of neurodegenerative diseases associated with the formation of stress granules. This compound is selected from lipoic acid, lipoamide, dihydrolipoic acid, and dihydrolipoamide. The invention also describes a method for identifying compounds that modulate characteristics associated with condensates, which involves contacting the compound with a cellular composition and determining the characteristic associated with the condensates. Another significant patent involves the use of glycolic acid and D-lactic acid for treating neurodegenerative diseases linked to a decline in mitochondrial activity. This method includes administering these compounds to individuals in need of treatment.
Career Highlights
Throughout his career, Anthony A Hyman has worked with notable organizations such as Cenix Bioscience GmbH and the Max Planck Society for the Advancement of Science. His research has been pivotal in advancing our understanding of neurodegenerative diseases and their treatment.
Collaborations
Hyman has collaborated with esteemed colleagues, including Christophe Echeverri and Steven J Jones. These partnerships have further enriched his research and contributions to the scientific community.
Conclusion
Anthony A Hyman's innovative work in the field of neurodegenerative diseases showcases his dedication to advancing medical science. His patents reflect a commitment to finding effective treatments for complex health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile